- The Medicines Company (NASDAQ:MDCO -0.4%) Q4 results: Revenues: $191M (+3.2%); COGS: $66M (-13.5%); R&D Expense: $53.5M (+39.0%); SG&A: $106.2M (+23.5%); Operating Loss: ($34.8M) (-118.9%); Net Loss: ($5.3M) (-541.7%); Loss Per Share: ($0.08) (-500.0%).
- FY2014 results: Revenues: $724.4M (+5.3%); COGS: $287.6M (+9.4%); R&D Expense: $159.2M (+8.4%); SG&A: $342.2M (+29.1%); Operating Loss: ($64.6M) (-589.4%); Net Loss: ($32.2M) (-307.7%); Loss Per Share: ($0.50) (-300.0%); Quick Assets: $370.7M (-1.6%).
- No guidance given.